Aurora Cannabis Inc. closed 54.01% short of its 52-week high of $9.35, which the company achieved on April 30th.
Aurora Cannabis Inc. closed 52.83% short of its 52-week high of $9.35, which the company reached on April 30th.
Aurora Cannabis produces and sells a variety of cannabis products, including dried cannabis, oils, capsules, and topical treatments, primarily for medical patients. It also manufactures and sells ...
Canada & Portugal lead supply. Javier Hasse This Week In Cannabis: DeSantis' Anti-Weed Push, NY's Drug Decriminalization, Aurora's Record Earnings, Tilray And More Global News Cannabis news ...
The year is a more than a month old, but Aurora Cannabis (NASDAQ: ACB) is already one of the hottest stocks to own in 2025. As of Feb. 11, the pot stock has soared more than 50% since the year ...
Analysts raised concerns about potential pricing impacts from increased competition in global medical cannabis markets. Martin emphasized Aurora’s competitive advantages, including regulatory ...
Aurora Cannabis (TSX:ACB) is expanding its pastille offerings in Australia, marking a significant step in the company’s move to diversify its range of medical cannabis products ・This expansion aims to ...
Reports Total Net Revenue of $88.2 Million, up 37% YoY, Including Record Net Revenue of $68.1 Million in Global Medical Cannabis, up 51% YoY. Aurora Cannabis Inc. shares T.ACB are trading up $2.00 at ...
Greetings and welcome to the Aurora Cannabis Inc. Third Quarter 2025 Results Conference Call. All participants will be in a listen-only mode and a question-and-answer session will follow the ...
Has Aurora Cannabis Inc. (ACB) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results